Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Su

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Pediatrics|April 21, 2023
COVID-19 Vaccine Safety First Year Findings in AdolescentsElisabeth M Hesse, Anne Hause, Tanya Myers, et al.
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) VaccinationErmias D Belay, Shana Godfred Cato, Agam K Rao, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.
The Lancet. Child & Adolescent Health|February 26, 2022
Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigationAnna R Yousaf, Margaret M Cortese, Allan W Taylor, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
The Journal of Infectious Diseases|February 23, 2023
Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022Margaret M Cortese, Allan W Taylor, Lara J Akinbami, et al.
The Lancet. Child & Adolescent Health|September 24, 2022
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Matthew E Oster, Karen R Broder, et al.
MMWR. Morbidity and Mortality Weekly Report|August 12, 2021
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021Hannah G Rosenblum, Stephen C Hadler, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022Megan Wallace, Danielle Moulia, Amy E Blain, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Pediatrics|April 21, 2023
COVID-19 Vaccine Safety First Year Findings in AdolescentsElisabeth M Hesse, Anne Hause, Tanya Myers, et al.
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) VaccinationErmias D Belay, Shana Godfred Cato, Agam K Rao, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.
The Lancet. Child & Adolescent Health|February 26, 2022
Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigationAnna R Yousaf, Margaret M Cortese, Allan W Taylor, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
The Journal of Infectious Diseases|February 23, 2023
Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022Margaret M Cortese, Allan W Taylor, Lara J Akinbami, et al.
The Lancet. Child & Adolescent Health|September 24, 2022
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Matthew E Oster, Karen R Broder, et al.
MMWR. Morbidity and Mortality Weekly Report|August 12, 2021
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021Hannah G Rosenblum, Stephen C Hadler, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022Megan Wallace, Danielle Moulia, Amy E Blain, et al.
Pageof 6